RCAMU
IONS icon

Rothschild & Co Asset Management US’s Ionis Pharmaceuticals IONS Stock Holding History

Rothschild & Co Asset Management US’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-222,045
Closed -$10.5M – 301
2020
Q3 		$10.5M Sell
222,045
-47,615
-18% -$2.64M 0.19% 188
2020
Q2 		$15.9M Sell
269,660
-74,367
-22% -$4.14M 0.23% 169
2020
Q1 		$16.3M Sell
344,027
-30,341
-8% -$1.69M 0.25% 151
2019
Q4 		$22.6M Buy
374,368
+127,346
+52% +$7.59M 0.24% 179
2019
Q3 		$14.8M Sell
247,022
-5,519
-2% -$360K 0.16% 218
2019
Q2 		$16.2M Sell
252,541
-34,735
-12% -$2.46M 0.17% 209
2019
Q1 		$23.3M Buy
287,276
+13,184
+5% +$850K 0.25% 158
2018
Q4 		$14.8M Sell
274,092
-1,829
-0.7% -$93.3K 0.18% 204
2018
Q3 		$14.2M Sell
275,921
-7,079
-3% -$333K 0.15% 234
2018
Q2 		$11.8M Buy
283,000
+2,449
+0.9% +$109K 0.13% 257
2018
Q1 		$12.4M Sell
280,551
-2,626
-0.9% -$133K 0.14% 233
2017
Q4 		$14.2M Buy
283,177
+2,109
+0.8% +$116K 0.15% 223
2017
Q3 		$14.3M Buy
281,068
+27,426
+11% +$1.44M 0.16% 209
2017
Q2 		$12.9M Buy
253,642
+13,520
+6% +$630K 0.15% 223
2017
Q1 		$9.65M Buy
240,122
+18,587
+8% +$835K 0.11% 245
2016
Q4 		$10.6M Buy
221,535
+16,188
+8% +$641K 0.13% 229
2016
Q3 		$7.52M Buy
205,347
+15,353
+8% +$480K 0.13% 243
2016
Q2 		$4.42M Buy
189,994
+32,936
+21% +$1.06M 0.08% 278
2016
Q1 		$6.36M Buy
+157,058
New +$6.38M 0.12% 237
2015
Q4 		– Sell
-5,486
Closed -$222K – 522
2015
Q3 		$222K Hold
5,486
– – ﹤0.01% 339
2015
Q2 		$316K Buy
+5,486
New +$349K 0.01% 333

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Rothschild & Co Asset Management US's IONS Position: Q4 2020 in Review

Rothschild & Co Asset Management US sold out of Ionis Pharmaceuticals (IONS) in Q4 2020, closing a stake of 222,045 shares — an estimated $10.5M sold.

Rothschild & Co Asset Management US first reported a position in IONS in Q2 2015 and held it in 21 quarters. The position peaked at $23.3M in Q1 2019. 382 funds tracked by Wall St. Rank hold IONS as of Q4 2020.

  • Rothschild & Co Asset Management US reported no remaining Ionis Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 222,045 Ionis Pharmaceuticals shares in Q4 2020, an estimated $10.5M.
  • Rothschild & Co Asset Management US first reported a position in Ionis Pharmaceuticals in Q2 2015 and held it in 21 quarters.
  • Rothschild & Co Asset Management US's Ionis Pharmaceuticals position peaked at $23.3M in Q1 2019.
  • 382 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2020.

Based on Rothschild & Co Asset Management US's 13F filing for Q4 2020, filed 8 Feb 2021.